Cargando…

Chemically Crosslinked Bispecific Antibodies for Cancer Therapy: Breaking from the Structural Restrictions of the Genetic Fusion Approach

Antibodies are composed of structurally and functionally independent domains that can be used as building blocks to construct different types of chimeric protein-format molecules. However, the generally used genetic fusion and chemical approaches restrict the types of structures that can be formed a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Asami, Umetsu, Mitsuo, Nakanishi, Takeshi, Hashikami, Kentaro, Nakazawa, Hikaru, Hattori, Shuhei, Asano, Ryutaro, Kumagai, Izumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037651/ https://www.ncbi.nlm.nih.gov/pubmed/31973200 http://dx.doi.org/10.3390/ijms21030711

Ejemplares similares

A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity
por: Sugiyama, Aruto, et al.
Publicado: (2017)

Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity
por: Asano, Ryutaro, et al.
Publicado: (2018)

Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats
por: Asano, Ryutaro, et al.
Publicado: (2020)

Functional Domain Order of an Anti-EGFR × Anti-CD16 Bispecific Diabody Involving NK Cell Activation
por: Kuwahara, Atsushi, et al.
Publicado: (2020)

Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction
por: Yamada, Risa, et al.
Publicado: (2023)

Affinity maturation of humanized anti-epidermal growth factor receptor antibody using a modified phage-based open sandwich selection method
por: Sanada, Hideaki, et al.
Publicado: (2018)

Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance
por: Suzuki, Saori, et al.
Publicado: (2018)

Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
por: Asano, Ryutaro, et al.
Publicado: (2014)

Anti‐EGFR scFv tetramer (tetrabody) with a stable monodisperse structure, strong anticancer effect, and a long in vivo half‐life
por: Asano, Ryutaro, et al.
Publicado: (2016)

Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery
por: Ando, Yu, et al.
Publicado: (2021)

T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
por: Kamakura, Daisuke, et al.
Publicado: (2021)

Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells
por: Kimura, Kouki, et al.
Publicado: (2023)

Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation
por: Kamakura, Daisuke, et al.
Publicado: (2020)

A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
por: Rosato, Francesca, et al.
Publicado: (2022)

Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing
por: Metz, Silke, et al.
Publicado: (2012)

Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning
por: Ito, Tomoyuki, et al.
Publicado: (2023)

Functional integration of protein A binding ability to antibody fragments for convenient and tag-free purification
por: Kuwahara, Atsushi, et al.
Publicado: (2023)

Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging
por: Darling, Tamarand Lee, et al.
Publicado: (2017)

A streamlined strain engineering workflow with genome-wide screening detects enhanced protein secretion in Komagataella phaffii
por: Ito, Yoichiro, et al.
Publicado: (2022)

Breaking In: Human Metapneumovirus Fusion and Entry
por: Cox, Reagan G., et al.
Publicado: (2013)

Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
por: Wang, Lili, et al.
Publicado: (2019)

Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015)

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

Breaking restricted taxonomic functionality by dual resistance genes
por: Narusaka, Mari, et al.
Publicado: (2013)

Staphylococcus aureus Biofilm Inhibiting Activity of Advanced Glycation Endproduct Crosslink Breaking and Glycation Inhibiting Compounds
por: Haasbroek, Kyle, et al.
Publicado: (2022)

Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5
por: Song, Jiang Ying, et al.
Publicado: (2020)

Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope
por: Makabe, Koki, et al.
Publicado: (2021)

BEAT(® )the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
por: Moretti, Pierre, et al.
Publicado: (2013)

DNA Double Strand Breaks but Not Interstrand Crosslinks Prevent Progress through Meiosis in Fully Grown Mouse Oocytes
por: Yuen, Wai Shan, et al.
Publicado: (2012)

Breaking and Connecting: Highly Hazy and Transparent Regenerated Networked-Nanofibrous Cellulose Films via Combination of Hydrolysis and Crosslinking
por: Aburabie, Jamaliah, et al.
Publicado: (2022)

Does the sixth wave of COVID‐19 break in Okinawa?
por: Tomochi, Masaki, et al.
Publicado: (2022)

BreakTrans: uncovering the genomic architecture of gene fusions
por: Chen, Ken, et al.
Publicado: (2013)

Homogeneous Bispecifics by Disulfide Bridging
por: Hull, Elizabeth A., et al.
Publicado: (2014)

Design and Production of Bispecific Antibodies
por: Wang, Qiong, et al.
Publicado: (2019)

Bispecific Antibodies for Diagnostic Applications
por: Parashar, Archana, et al.
Publicado: (2011)

Bispecific Antibodies and Gene Therapy
por: Nettelbeck, Dirk M.
Publicado: (2011)

An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer
por: Guo, Xiao-Fang, et al.
Publicado: (2014)

Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins
por: Surowka, Marlena, et al.
Publicado: (2021)

The mechanism of action and biodistribution of a novel EGFR/VEGF bispecific fusion protein that exhibited superior antitumor activities
por: Deng, Lan, et al.
Publicado: (2023)

Dispersion of break energy in the GRB internal shock model
por: Asano, K, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_5gqn1gssse0th64unontn2iaf2